

The SPIRIT–CONSORT Group
The SPIRIT-CONSORT Group is an international and eclectic group, comprising trialists, methodologists, journal editors and most recently patient representatives. Just as the SPIRIT and CONSORT Statements are tools that evolve in response to the emerging evidence, the membership of the SPIRIT–CONSORT Group is dynamic, evolving in response to emerging projects and needed expertise.
Funding
SPIRIT and CONSORT receive some limited funding to support, coordination and research work. This funding is greatly appreciated by the SPIRIT–CONSORT Group, and has enabled some aspects of the work to be funded that were never before formally supported.
The history of CONSORT funding is as follows:
• Medical Research Council–National Institute for Health and Care Research, UK (2022–2024, Better Methods,
Better Research [MR/W020483/1])
• Medical Research Council, UK (2006–2015)
• US National Library of Medicine (1999–2004)
The history of SPIRIT funding is as follows:
• Medical Research Council–National Institute for Health and Care Research, UK (2022–2024, Better Methods,
Better Research [MR/W020483/1])
• Canadian Institutes of Health Research
- Dissemination Events grant (2012–13, Ethics MET-117434)
- Dissemination Events grant (2010, Ethics DET-106068)
- Workshop grant (2007)
• Canadian Agency for Drugs and Technologies in Health
- Workshop grant (2009)
• National Cancer Institute of Canada
- Workshop grant (2007)
• Women’s College Hospital, Canada
- In-kind support (2009–present)
In addition, we gratefully acknowledge these organisations and individuals for their financial support of the following CONSORT activities:
CONSORT Group Meeting 2011
• President’s Fund – Canadian Institutes of Health Research
• Johnson & Johnson
• Pfizer USA
• AstraZeneca
• GlaxoSmithKline
​
CONSORT Group Meeting 2007
• UK National Co-ordinating Centre for Research Methodology
• American Society of Clinical Oncology
• Canadian Institutes of Health Research
• Johnson & Johnson
• BMJ
• UK Cochrane Centre
• Nordic Cochrane Centre
• The Lancet
• PLoS Medicine
CONSORT Group Meetings 1999 and 2000
• Abbott Laboratories
• American College of Physicians/American
Society of Internal Medicine
• GlaxoWellcome, Inc. (now part of SmithKline
Beecham, Inc.)
• The Lancet
• Merck & Co., Inc.
• Canadian Institutes of Health Research
• US National Library of Medicine
• TAP Pharmaceutical Products, Inc.
• BMJ
• Council of Science Editors
• International Committee of Medical Journal
Editors (Vancouver Group)